IP Library Granted Patent US 9,796,731
Granted Patent B2
US 9,796,731 · App. 15/269,163 · Granted Oct 24, 2017

Methods for the acylation of maytansinol

Inventors: Wayne C. Widdison (Belmont, MA); Robert Yongxin Zhao (Lexington, MA)
Assignee: IMMUNOGEN, INC.
C07D498/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,796,731
App. No.
15/269,163
Granted
Oct 24, 2017
Kind
B2
Abstract

Disclosed is a method of preparing an amino acid ester of maytansinol by reacting maytansinol with an N-carboxyanhydride of an amino acid (NCA) in the presence of a drying agent. Also disclosed is an improved method of preparing an amino acid ester of maytansinol in which a nucleophile is added to the reaction mixture after completion of the reaction between maytansinol and an N-carboxyanhydride of an amino acid.

Claims (18)

1. A method of preparing a compound represented by the following formula:

the method comprising:

a) reacting maytansinol with an N-carboxyanhydride in a reaction mixture additionally comprising diisopropylethylamine and zinc triflate, wherein the N-carboxyanhydride is represented by the following formula:

thereby forming the compound of Formula (1);

b) reacting unreacted N-carboxyanhydride from the reaction mixture in step a) with methanol.

2. The method of claim 1 , wherein the reaction mixture in step a) further comprises a drying agent.

3. The method of claim 1 , wherein the method further comprises contacting the reaction mixture after step b) with an aqueous solution containing bicarbonate or carbonate or contacting the reaction mixture with a metal scavenger.

4. The method of claim 1 , further comprising the step of reacting the compound of formula d(1) with a carboxylic acid having the formula R 3 COOH in the presence of a condensing agent or with an activated carboxylic acid having the formula R 3 COX, to form a compound represented by the following formula:

wherein R 3 is —Y—S—SR 4 ; Y is —CH 2 CH 2 — or —CH 2 CH 2 C(CH 3 ) 2 —; R 4 is —CH 3 ; —COX is a reactive ester selected from the group consisting of N-succinimidyl, N-sulfosuccinimidyl, N-phthalimidyl, N-sulfophthalimidyl, 2-nitrophenyl, 4-nitrophenyl, 2,4-dinitrophenyl, 3-sulfonyl-4-nitrophenyl and 3-carboxy-4-nitrophenyl ester; and the condensing agent is a carbodiimide.

5. The method of claim 4 , further comprising reacting the compound of formula (3) with a reducing agent to form a compound represented by the following formula:

6. The method of claim 4 , wherein the condensing agent is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC).

7. The method of claim 2 , wherein the drying agent is a molecular sieve, sodium sulfate, calcium sulfate, calcium chloride, or magnesium sulfate.

8. The method of claim 7 , wherein the drying agent is sodium sulfate.

9. The method of claim 4 , wherein the reactive ester is N-succinimidyl ester.

10. The method of claim 5 , wherein the reducing agent is dithiothreitol (DTT), (tris(2-carboxyethyl)phosphine) (TCEP) or NaBH 4 .

11. The method of claim 5 , wherein the reducing agent is dithiothreitol (DTT).

12. The method of claim 5 , wherein the compound of formula (4) is DM4 represented by the following formula:

13. The method of claim 5 , wherein the compound of formula (4) is DM1 represented by the following formula:

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2016
From: WIDDISON, WAYNE C.; ZHAO, ROBERT YONGXIN
To: IMMUNOGEN, INC.
Reel/Frame 040056/0563 →
Continuity (4)
Continuation 14660050 · Mar 17, 2015
Continuation 14037657 · Sep 26, 2013
Provisional Application 61705731 · Sep 26, 2012
Related Publication 20170137440A1 · May 18, 2017